ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,922Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 337

$1.05M Total Retail Price of All Prescriptions

Rank: 8 out of 337

484 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 484 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

12% of this provider’s 484 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 14,158 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
FUROSEMIDE 751 684 1 8
SIMVASTATIN 694 524 2 1
WARFARIN SODIUM 648 589 3 11
LISINOPRIL 599 421 4 2
AMLODIPINE BESYLATE 568 453 5 3
HYDROCODONE-ACETAMINOPHEN 498 259 S3 6 13
OMEPRAZOLE 494 279 7 4
METOPROLOL TARTRATE 457 363 8 6
NAMENDA 412 399 9 35
LEVOTHYROXINE SODIUM 396 325 10 5
CITALOPRAM HBR 303 259 11 17
MIRTAZAPINE 297 271 12 27
HYDROCHLOROTHIAZIDE 284 211 13 9
SERTRALINE HCL 272 235 14 18
ATENOLOL 261 213 15 10
ALENDRONATE SODIUM 234 171 16 19
DONEPEZIL HCL 229 204 17 22
TRAZODONE HCL 223 185 18 16
METFORMIN HCL 212 133 19 12
ATORVASTATIN CALCIUM 192 143 20 7
EXELON 190 190 21 85
PANTOPRAZOLE SODIUM 180 153 22 36
OXYCODONE HCL 165 86 S2 23 63
ESCITALOPRAM OXALATE 159 148 24 66
DIOVAN 157 143 25 26
OXYCODONE-ACETAMINOPHEN 154 64 S2 26 84
FLUTICASONE PROPIONATE 148 104 27 34
PRAVASTATIN SODIUM 137 113 28 14
VENLAFAXINE HCL ER 134 121 29 86
CYMBALTA 133 103 30 59
SYNTHROID 131 64 31 41
RANITIDINE HCL 130 96 32 30
LOSARTAN POTASSIUM 124 115 33 15
NEXIUM 123 79 34 56
METOPROLOL SUCCINATE 120 94 35 21
LEVOFLOXACIN 120 112 35 93
MELOXICAM 118 48 37 54
QUETIAPINE FUMARATE 113 87 38 61
FAMOTIDINE 113 101 38 115
SPIRIVA 113 105 38 43
TAMSULOSIN HCL 112 93 41 25
LIDODERM 108 106 42 82
IBUPROFEN 106 65 43 64
GABAPENTIN 105 84 44 20
ADVAIR DISKUS 102 92 45 44
POTASSIUM CHLORIDE 98 98 46 62
ISOSORBIDE MONONITRATE ER 97 86 47 70
FINASTERIDE 97 89 47 83
PROAIR HFA 96 72 49 38
TRAMADOL HCL 96 74 49 32
CARVEDILOL 95 76 51 73
METOCLOPRAMIDE HCL 95 45 51 185
DIGOXIN 93 93 53 58
IPRATROPIUM-ALBUTEROL 93 93 53 96
ZOLPIDEM TARTRATE 88 48 55 23
ENALAPRIL MALEATE 87 56 56 37
AZITHROMYCIN 86 60 57 51
FENTANYL 84 43 S2 58 138
CRESTOR 84 34 58 29
LANTUS 83 50 60 49
CARBIDOPA-LEVODOPA 82 82 61 92
POLYETHYLENE GLYCOL 3350 81 24 62 47
JANUMET 78 56 63 201
GEMFIBROZIL 76 58 64 114
BACLOFEN 74 33 65 133
CARBAMAZEPINE 71 33 66 207
CYCLOBENZAPRINE HCL 71 14 R 66 103
BISOPROLOL FUMARATE 70 58 68 67
DIVALPROEX SODIUM 69 0 69 101
SINGULAIR 69 40 69 113
ALLOPURINOL 69 65 69 28
KLOR-CON M20 65 65 72 65
NYSTOP 65 55 72 140
LEXAPRO 62 60 74 169
SEROQUEL 62 52 74 107
CLOPIDOGREL 62 46 74 42
COLCRYS 60 46 77 128
PREDNISONE 59 56 78 40
RIVASTIGMINE 57 57 79 208
GLYBURIDE 57 45 R 79 53
AMITRIPTYLINE HCL 57 24 R 79 75
CELEBREX 56 49 82 116
LOVASTATIN 55 51 83 24
NOVOLOG 55 40 83 106
GLIPIZIDE 55 55 83 45
DIOVAN HCT 53 46 86 88
CALCITONIN-SALMON 52 52 87 195
LIPITOR 52 52 87 33
OXYBUTYNIN CHLORIDE ER 51 34 89 124
OXYCONTIN 51 26 S2 89 87
METFORMIN HCL ER 50 47 91 52
VERAPAMIL ER 50 50 91 77
JANUVIA 50 33 91 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 28, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.